Izutani H, Miyagawa S, Mikata S, Shirakura R, Matsuda H
First Department of Surgery, Osaka University Medical School, Japan.
Transpl Immunol. 1997 Mar;5(1):11-5. doi: 10.1016/s0966-3274(97)80020-2.
Graft coronary arteriosclerosis occurs as chronic rejection after heart transplantation. In the previous studies, we have examined the minimum period of allogeneic stimulation to induce this change, using heterotopic rat heart transplantation and a retransplantation model. Retransplantation of allografts back into the donor strain did not prevent graft arteriosclerosis if the grafts had resided in the primary recipient for up to five days. In this study, the participation of the T cell subset causing graft coronary arteriosclerotic change was assessed using the same model. The transplanted rats in fully allogeneic or non-MHC antigen mismatch combinations were treated with a short-course administration of FK506. The graft was removed and retransplanted into the donor strain rats to escape from further immunological stimulation. CD4+ T cells and/or CD8+ T cells of first recipient rats in both combinations were eliminated by monoclonal antibodies. The grade of arteriosclerosis in the retransplanted hearts was evaluated on a basis of a scale from 0-4 according to the histological appearance of the vessel injury on day 40 after initial engraftment. While neither anti-CD4 nor anti-CD8 monoclonal antibody alone had little effect, the administration of both mAbs reduced this arteriosclerotic change and development. In conclusion, the T cell subsets, CD4+ T cell and CD8+ T cell play a certain role in the induction of the graft coronary arteriosclerotic change.
移植冠状动脉硬化是心脏移植后发生的慢性排斥反应。在之前的研究中,我们使用异位大鼠心脏移植和再移植模型,研究了诱导这种变化所需的同种异体刺激的最短时间。如果同种异体移植物在初次受体中停留长达五天,将其重新移植回供体品系并不能预防移植物动脉硬化。在本研究中,使用相同模型评估了导致移植物冠状动脉硬化改变的T细胞亚群的作用。将完全同种异体或非MHC抗原不匹配组合的移植大鼠用短疗程的FK506进行治疗。移除移植物并将其重新移植到供体品系大鼠中,以避免进一步的免疫刺激。通过单克隆抗体消除两种组合中初次受体大鼠的CD4+T细胞和/或CD8+T细胞。根据初次植入后第40天血管损伤的组织学表现,将再移植心脏的动脉硬化程度按0-4级进行评估。单独使用抗CD4或抗CD8单克隆抗体几乎没有效果,但同时给予两种单克隆抗体可减少这种动脉硬化改变和发展。总之,T细胞亚群CD4+T细胞和CD8+T细胞在诱导移植物冠状动脉硬化改变中起一定作用。